Cortechs.ai | RANO 2D and 3D Measurements as a Companion Diagnostic Tool in NeuroQuant Brain Tumor

RANO 2D and 3D Measurements as a Companion Diagnostic Tool in NeuroQuant Brain Tumor

When it comes to brain tumor diagnosis and management, accurate measurement is crucial for guiding treatment decisions and monitoring patient progress. The Response Assessment in Neuro-Oncology (RANO) criteria, which rely on both 2D and 3D measurements, have become the standard for evaluating brain tumor size and response to treatment.

The Importance of Accurate Tumor Measurement

For patients with brain tumors, small differences in measurements can have a significant impact on treatment outcomes. Traditional 2D measurements, while effective, have limitations when it comes to capturing the full scope of tumor growth or reduction. This is where 3D measurements come in, offering a more comprehensive view of tumor size and shape.

How NeuroQuant Streamlines RANO Measurements

NeuroQuant’s Brain Tumor module simplifies the RANO measurement process by automatically segmenting and quantifying tumors in both 2D and 3D. By providing clinicians with consistent, accurate data, NeuroQuant reduces the time spent manually analyzing scans and enhances diagnostic precision. With the ability to model tumors in three dimensions, clinicians can better assess tumor volume and progression, improving treatment planning.

In conclusion, NeuroQuant’s integration of RANO 2D and 3D measurements provides a powerful companion diagnostic tool for clinicians. By automating this process, NeuroQuant ensures that healthcare providers can make more informed decisions, ultimately improving patient outcomes.

More Resources

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.

06/27/2025

Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports

Accurate, objective data is important in the effort to standardize reporting on vascular lesions and their associated pathologies.

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

06/11/2025

Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region

We’re excited to announce our new partnership with RMS Medical Devices to our advanced neuroimaging and prostate imaging solutions to the Benelux region

06/04/2025

Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology

Press Release: Delivering Clinically Validated AI Solutions for Enhanced Imaging Precision and Workflow Efficiency

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology
Scroll to Top